2020Diabetes Technology & TherapeuticsOpen access

Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems

Yu Kuei Lin, Danielle Groat, Owen Chan, Man Hung, Anu Sharma, Michael W. Varner, Ramkiran Gouripeddi, Julio C. Facelli, Simon J. Fisher

Open full text 39 citations

Abstract

Background: Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods: For this cross-sectional observational study, 99 T1D patients using real-time CGMs for ≥86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results: IAH was associated with greater percentages of CGM values <70 and <54 mg/dL ( P = 0.012, P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL ( P = 0.013, P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at ≥1 time point ( P = 0.048, P = 0.003) or lasting ≥20 min ( P = 0.016, P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL ( P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL ( P = 0.009, P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL ( P < 0.001, P = 0.006), respectively. Conclusions: T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.

About this research paper

What this paper is about

Background: Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods: For this cross-sectional observational study, 99 T1D patients using real-time CGMs for ≥86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results: IAH was associated with greater percentages of CGM values <70 and <54 mg/dL ( P = 0.012, P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL ( P = 0.013, P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at ≥1 time point ( P = 0.048, P = 0.003) or lasting ≥20 min ( P = 0.016, P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL ( P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL ( P = 0.009, P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL ( P < 0.001, P = 0.006), respectively. Conclusions: T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.

Why it matters

OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: Continuous glucose monitoring (CGM) systems help reduce hypoglycemia in patients with type 1 diabetes (T1D). It remains unclear whether T1D patients with impaired awareness of hypoglycemia (IAH) continue to develop more hypoglycemia than those with normal hypoglycemia awareness (NA) despite CGM use. Materials and Methods: For this cross-sectional observational study, 99 T1D patients using real-time CGMs for ≥86% of time were recruited. Fifty and 49 patients were found to have NA and IAH (based on the Clarke questionnaire), respectively. Two-week CGM hypoglycemia data were collected. Results: IAH was associated with greater percentages of CGM values <70 and <54 mg/dL ( P = 0.012, P = 0.004) compared to NA. Clarke scores correlated positively with the percentage of CGM values <70 and <54 mg/dL ( P = 0.013, P = 0.004). IAH was also related to more events with glucose <70 and <54 mg/dL determined either with at ≥1 time point ( P = 0.048, P = 0.003) or lasting ≥20 min ( P = 0.016, P = 0.004). IAH patients presented with more day-time events with glucose <54 mg/dL ( P = 0.015), nocturnal events with glucose levels <70 and <54 mg/dL ( P = 0.009, P = 0.007) and longer day-time event duration with glucose levels <70 and <54 mg/dL ( P < 0.001, P = 0.006), respectively. Conclusions: T1D patients with IAH continue to experience more hypoglycemia despite dedicated CGM use.

Key concepts: Hypoglycemia, Medicine, Continuous glucose monitoring, Type 1 diabetes, Diabetes mellitus, Internal medicine, Type 2 diabetes, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Associations Between the Time in Hypoglycemia and Hypoglycemia Awareness Status in Type 1 Diabetes Patients Using Continuous Glucose Monitoring Systems — Research Paper | ScholarLens